Intuitive Surgical (NASDAQ:ISRG) Shares Gap Down Following Analyst Downgrade

Posted by Brian Himes on Oct 21st, 2026

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) gapped down before the market opened on Wednesday after Royal Bank Of Canada lowered their price target on the stock from $575.00 to $550.00. The stock had previously closed at $438.00, but opened at $402.50. Royal Bank Of Canada currently has an outperform rating on the stock. Intuitive Surgical shares last traded at $417.6190, with a volume of 1,142,782 shares.

Several other brokerages have also commented on ISRG. Citigroup decreased their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Truist Financial dropped their target price on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research report on Thursday, July 16th. Leerink Partners cut their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. Evercore set a $430.00 price objective on shares of Intuitive Surgical in a research note on Monday, July 6th. Finally, Mizuho dropped their price objective on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a report on Wednesday. Twenty-five investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $497.39.

Read Our Latest Research Report on ISRG

Insider Transactions at Intuitive Surgical

In related news, Director Gary S. Guthart sold 10,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the transaction, the director directly owned 1,245,679 shares in the company, valued at $498,271,600. The trade was a 0.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 1,089 shares of the company’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total transaction of $407,765.16. Following the completion of the sale, the vice president directly owned 1,026 shares in the company, valued at approximately $384,175.44. The trade was a 51.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is owned by corporate insiders.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Intuitive Surgical reported third-quarter revenue of $3.05 billion, up 21.7% year over year and above the approximately $2.91 billion analyst estimate. Adjusted earnings of $3.00 per share also exceeded consensus, while worldwide procedures increased about 15% and da Vinci system placements rose to 546 from 427 a year earlier. Intuitive Surgical Q3 Earnings and Revenues Top Estimates
Positive Sentiment: Several analysts remain constructive: Bernstein reaffirmed a Buy rating with a $685 price target, BTIG maintained Buy, Baird raised its target to $550, and Erste Group upgraded the stock to Buy. These actions reflect confidence in robotic-surgery demand, the da Vinci platform and Intuitive’s innovation pipeline. Analyst Ratings and Price Target
Neutral Sentiment: RBC Capital retained its Outperform rating while lowering its target to $550 from $575. Raymond James also trimmed its target to $480 from $483, while Mizuho cut its target to $400 and kept a Neutral rating, creating a mixed analyst picture. RBC Capital Price Target Update
Negative Sentiment: GAAP profit fell to $1.49 per share because Intuitive recorded a $450 million pretax charge, or approximately $0.99 per share after tax, tied to a proposed antitrust settlement. The settlement still requires court approval, adding legal and earnings uncertainty. Antitrust Settlement Charge
Negative Sentiment: Management narrowed its 2026 global da Vinci procedure-growth forecast to 14%-15%. Planned actions to reduce per-procedure instrument costs by roughly 3%-5% may support long-term adoption but could pressure near-term revenue and margins. Reports also highlighted a slowdown in U.S. procedure growth, which amplified the market’s reaction. Intuitive Narrows Procedure Growth Outlook

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors have recently modified their holdings of the stock. North Point Portfolio Managers Corp OH purchased a new position in Intuitive Surgical during the third quarter valued at approximately $27,000. Main Street Group LTD acquired a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. Compass Financial Management LLC acquired a new position in Intuitive Surgical in the second quarter valued at approximately $30,000. Vermillion Wealth Management Inc. boosted its position in Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 25 shares in the last quarter. Finally, Evergreen Advisors LLC purchased a new stake in Intuitive Surgical in the 1st quarter worth approximately $35,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 2.7%

The firm has a market cap of $150.55 billion, a PE ratio of 48.45, a price-to-earnings-growth ratio of 3.27 and a beta of 1.46. The company has a 50-day simple moving average of $392.96 and a 200 day simple moving average of $409.06.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the firm earned $2.40 EPS. On average, equities analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.